70 related articles for article (PubMed ID: 11699327)
41. Evening salivary alpha-amylase, major depressive disorder, and antidepressant use in the Netherlands Study of Depression and Anxiety (NESDA).
Veen G; Giltay EJ; Licht CM; Vreeburg SA; Cobbaert CM; Penninx BW; Zitman FG
Psychiatry Res; 2013 Jun; 208(1):41-6. PubMed ID: 23587658
[TBL] [Abstract][Full Text] [Related]
42. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
43. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
[TBL] [Abstract][Full Text] [Related]
44. A case series on the use of lavendula oil capsules in patients suffering from major depressive disorder and symptoms of psychomotor agitation, insomnia and anxiety.
Fißler M; Quante A
Complement Ther Med; 2014 Feb; 22(1):63-9. PubMed ID: 24559818
[TBL] [Abstract][Full Text] [Related]
45. Correlates of residual fatigue in patients with major depressive disorder: The role of psychotropic medication.
Chung KF; Yu YM; Yeung WF
J Affect Disord; 2015 Nov; 186():192-7. PubMed ID: 26247911
[TBL] [Abstract][Full Text] [Related]
46. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
[TBL] [Abstract][Full Text] [Related]
47. Identify abnormalities in resting-state brain function between first-episode, drug-naive major depressive disorder and remitted individuals: a 3-year retrospective study.
Yang C; Zhang A; Jia A; Ma JX; Sun N; Wang Y; Li X; Liu Z; Liu S; Xu Y; Zhang K
Neuroreport; 2018 Aug; 29(11):907-916. PubMed ID: 29912848
[TBL] [Abstract][Full Text] [Related]
48. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
49. The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years.
Zimmerman M; Holst CG; Clark HL; Multach M; Walsh E; Rosenstein LK; Gazarian D
CNS Drugs; 2016 Dec; 30(12):1209-1218. PubMed ID: 27541608
[TBL] [Abstract][Full Text] [Related]
50. Time course for memory dysfunction in early-life and late-life major depression: a longitudinal study from the Juntendo University Mood Disorder Project.
Maeshima H; Baba H; Nakano Y; Satomura E; Namekawa Y; Takebayashi N; Nomoto H; Suzuki T; Mimura M; Arai H
J Affect Disord; 2013 Oct; 151(1):66-70. PubMed ID: 23769611
[TBL] [Abstract][Full Text] [Related]
51. Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: differential effect of antidepressant treatment.
Rivero G; Gabilondo AM; García-Sevilla JA; La Harpe R; Callado LF; Meana JJ
J Affect Disord; 2014; 167():343-50. PubMed ID: 25020269
[TBL] [Abstract][Full Text] [Related]
52. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
Akkaya C; Sivrioglu EY; Akgoz S; Eker SS; Kirli S
Hum Psychopharmacol; 2006 Jul; 21(5):337-45. PubMed ID: 16856215
[TBL] [Abstract][Full Text] [Related]
53. Antidepressants Improve Negative Regulation of Toll-Like Receptor Signaling in Monocytes from Patients with Major Depression.
Hung YY
Neuroimmunomodulation; 2018; 25(1):42-48. PubMed ID: 29898456
[TBL] [Abstract][Full Text] [Related]
54. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment.
Vythilingam M; Vermetten E; Anderson GM; Luckenbaugh D; Anderson ER; Snow J; Staib LH; Charney DS; Bremner JD
Biol Psychiatry; 2004 Jul; 56(2):101-12. PubMed ID: 15231442
[TBL] [Abstract][Full Text] [Related]
55. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status.
Spruit MA; Thomeer MJ; Gosselink R; Troosters T; Kasran A; Debrock AJ; Demedts MG; Decramer M
Thorax; 2005 Jan; 60(1):32-8. PubMed ID: 15618580
[TBL] [Abstract][Full Text] [Related]
56. Isokinetic muscle performance in major depressive disorder: alterations by antidepressant therapy.
Bilici M; Koroglu MA; Cakirbay H; Guler M; Tosun M; Aydin T; Tan U
Int J Neurosci; 2001 Aug; 109(3-4):149-64. PubMed ID: 11699327
[TBL] [Abstract][Full Text] [Related]
57. Isokinetic muscle performance in major depressive disorder: alterations by antidepressant therapy.
Bilici M; Cakirbay H; Koroglu MA; Guler M; Tosun M; Aydin T; Tan U
Int J Neurosci; 2001 Sep; 110(1-2):9-23. PubMed ID: 11697214
[TBL] [Abstract][Full Text] [Related]
58. Aberrant Expression of Intracellular let-7e, miR-146a, and miR-155 Correlates with Severity of Depression in Patients with Major Depressive Disorder and Is Ameliorated after Antidepressant Treatment.
Hung YY; Wu MK; Tsai MC; Huang YL; Kang HY
Cells; 2019 Jun; 8(7):. PubMed ID: 31252530
[TBL] [Abstract][Full Text] [Related]
59. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
Hung YY; Lin CC; Kang HY; Huang TL
Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
[TBL] [Abstract][Full Text] [Related]
60. Low cocaine- and amphetamine-regulated transcript (CART) peptide levels in human cerebrospinal fluid of major depressive disorder (MDD) patients.
Yoon HS; Hattori K; Sasayama D; Kunugi H
J Affect Disord; 2018 May; 232():134-138. PubMed ID: 29486339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
